Finally, our findings have the potential to inform patient stratification in other immune-mediated inflammatory diseases such as inflammatory bowel disease and rheumatoid arthritis where TNF-blockade is also a therapeutic cornerstone41,45. This evidence concerns the gene TNF and inflammatory bowel disease.